R. Narayanan

发表

Druggable Vitiligo Genome: A Fast Track Approach to Take the Genome Wide Association to the Clinic

R. Narayanan, 2015 .

Big Data Analytics and Cancer

R. Narayanan, Amy Makler, 2016 .

Cancer gene discovery using digital differential display.

R. Narayanan, M. Jahanzeb, D. Scheurle, 2000, Cancer research.

Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer.

R. Narayanan, D. Scheurle, Maurice Phil De Young, 2002, In vivo.

Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors

R. Narayanan, M. P. Deyoung, M. Tress, 2003, Proceedings of the National Academy of Sciences of the United States of America.

2 Bioinformatics Approaches to Cancer Gene Discovery

R. Narayanan, 2017 .

Open reading frames associated with cancer in the dark matter of the human genome.

R. Narayanan, A. P. Delgado, Pamela Brandao, 2014, Cancer genomics & proteomics.

Bioinformatics approaches to cancer gene discovery.

R. Narayanan, Ramaswamy Narayanan, 2007, Methods in molecular biology.

Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.

Patricia Keating, R. Narayanan, M. P. Deyoung, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target.

R. Narayanan, M. P. Deyoung, M. Tress, 2003, Cancer letters.

Down's syndrome-associated single minded gene as a novel tumor marker.

R. Narayanan, D. Scheurle, M. P. Deyoung, 2002, Anticancer Research.

Atlas of the Open Reading Frames in Human Diseases: Dark Matter of the Human Genome

Ugis Sarkans, Mohammadreza Shojatalab, R. Narayanan, 2015 .

Neurodegenerative Diseases: Phenome to Genome Analysis

R. Narayanan, Ramaswamy Narayanan, 2014 .

Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers

R. Narayanan, A. P. Delgado, Pamela Brandao, 2014 .

Druggable cancer secretome: neoplasm-associated traits.

R. Narayanan, 2015, Cancer genomics & proteomics.

A novel transmembrane glycoprotein cancer biomarker present in the X chromosome.

R. Narayanan, A. P. Delgado, Pamela Brandao, 2014, Cancer genomics & proteomics.

Zika virus Therapeutics: Drug Targets and Repurposing Medicine from the Human Genome

R. Narayanan, 2016 .

Repurposing drugs in the genomics era: bioinformatics approaches

R. Narayanan, 2016 .

Ebola-associated genes in the human genome: implications for novel targets

R. Narayanan, 2014 .

Relevant genomics of neurotensin receptor in cancer.

R. Narayanan, J. Elek, W. Pinzon, 2000, Anticancer research.

Noncoding RNAs: the fourth dimension of the human genome

R. Narayanan, C. Schmidt, 2015 .

Druggableness of the Ebola Associated Genes in the Human Genome: Chemoinformatics Approaches

R. Narayanan, 2015 .

Zika virus therapeutic lead compounds discovery using chemoinformatics approaches

R. Narayanan, 2016 .

Antisense RNA to the Putative Tumor Suppressor Gene “Deleted in Colorectal Cancer” Transforms Fibroblasts

Kathleen R. Cho, B. Vogelstein, R. Narayanan, 1992, Annals of the New York Academy of Sciences.

HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test.

R. Narayanan, M. Jahanzeb, D. Scheurle, 2000, Anticancer research.

Mining Exosomal Genes for Pancreatic Cancer Targets.

R. Narayanan, Amy Makler, 2017, Cancer genomics & proteomics.

An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma

R. Narayanan, Amy Makler, W. Asghar, 2022, Biosensors.

New antiproliferative epoxysecosterols from Pseudopterogorgia americana

R. Narayanan, S. Naz, R. Kerr, 2000 .

Microarray-based expression profiling in prostate tumors.

R. Narayanan, J. Elek, J Elek, 2000, In vivo.

The Human Genome and the Clinic: Impact of Clinical Genomics to Patient’s Bedside

R. Narayanan, Amy Makler, 2016 .

Phenome-genome association studies of pancreatic cancer: new targets for therapy and diagnosis.

R. Narayanan, 2015, Cancer genomics & proteomics.

Diabetes associated genes from the dark matter of the human proteome

R. Narayanan, Ao, A. P. Delgado, 2014 .

Antisense oligodeoxynucleotides

R. Narayanan, C. Stein, R. Narayanan, 1994, Current opinion in oncology.

NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis.

P. Rameshwar, R. Narayanan, T. Denny, 2000, Journal of immunology.

Gene Selection for Microarray Expression Data with Imbalanced Sample Distributions

Xingquan Zhu, Ramaswamy Narayanan, Abu H. M. Kamal, 2009, 2009 International Joint Conference on Bioinformatics, Systems Biology and Intelligent Computing.

Data Intensive Computing: A Biomedical Case Study in Gene Selection and Filtering

Taghi M. Khoshgoftaar, Imad Mahgoub, Xingquan Zhu, 2011 .

Expression profile of the putative catalytic subunit of the telomerase gene.

Y. Shinkai, U. Eppenberger, R. Narayanan, 1998, Cancer research.

Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative

S. Ruben, J. F. Klement, C. H. Chen, 1992, Molecular and cellular biology.

Electronic health records in the genomics era: impact of clinical genomics

R. Narayanan, 2015 .